Rescue of mice homozygous for lethal albino deletions: implications for an animal model for the human liver disease tyrosinemia type 1.
Open accessAbstract
Mice homozygous for specific deletions around the albino locus on chromosome 7 die within the first few hours of birth. They have a complex phenotype in liver and kidney, which includes multiple changes in gene expression and ultrastructural abnormalities. On the basis of this phenotype, it was proposed that these deletions remove a regulatory locus, alf or hsdr-1. Recently, we and others showed that the gene for fumarylacetoacetate hydrolase (Fah), an enzyme involved in tyrosine catabolism, was disrupted by the lethal albino deletion c14CoS. The finding that the Fah gene in wild-type mice is highly expressed only in cell types that develop a phenotype in mutants, and the fact that Fah deficiency determines the human liver disease hereditary tyrosinemia type 1 (HT1), suggested that disruption of the Fah gene was responsible for the lethal albino phenotype. To test this hypothesis, we have created lines of mice carrying Fah transgenes. We find that c14CoS homozygotes which express transgenic Fah are complemented for all aspects of the complex lethal albino phenotype. Moreover, the degree to which the phenotype is corrected depends on the level of transgenic Fah expression. These results unequivocally establish Fah as the gene mapping at alf/hsdr-1 and prove that the phenotype depends ultimately on the blockage of tyrosine metabolism. Finally, they suggest lethal albino mice as an animal model for HT1.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Phenotype correction experiments using Fah transgenes expressed in mice homozygous for an Fah deletion, c14CoS, showed that Fah complements all aspects of the null phenotype except in lines manifesting very low liver expression of the transgene.
“Phenotype correction experiments using Fah transgenes (25) expressed in mice homozygous for an Fah deletion, c14CoS, showed that Fah complements all aspects of the null phenotype except in lines manifesting very low liver expression of the transgene.”
From Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1 (2001) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553 · see citing works
Gluecksohn-Waelsch, S. (1979) · Cell · doi:10.1016/0092-8674(79)90001-1 · Cited by 218 · see citing works
Ruppert, S., Kelsey, G., Schedl, A., Schmid, E., Thies, E., & Schütz, G. (1992) · Genes & Development · doi:10.1101/gad.6.8.1430 · Cited by 95 · see citing works
Self-citationKelsey, G., Schedl, A., Ruppert, S., Niswander, L., Magnuson, T., Klebig, M. L., Rinchik, E. M., & Schütz, G. (1992) · Genomics · doi:10.1016/s0888-7543(05)80217-4 · Cited by 28 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 16
- DeFranco, D., S.M. Morris, C.M. Leonard, and S. Glueeksohn- Waelsch. 1988. Metallothionein mRNA expression in mice homozygous for chromosomal deletions around the albino locus. Proc. Natl. Acad. Sci. 85: 1161-1164.
- DeFranco, D., D. Bali, R. Tortes, R.A. DePinho, R.P. Erickson, and S. Gluecksohn-Waelsch. 1991. The glucocortieoid hor- mone signal transduction pathway in mice homozygous for chromosomal deletions causing failure of cell type-specific inducible gene expression. Proc. Natl. Acad. Sci. 88: 5607- 5610.
- Erickson, R.P., S. Gluecksohn-Waelsch, and C. Cori 1968. Glu- cose-6-phosphatase deficiency caused by radiation-induced alleles at the albino locus in the mouse. Proc. Natl. Acad. Sci. 59: 437--444.
- Goldsmith, L.A. and C. Laberge. 1989. Tyrosinemia and related disorders. In The metabolic basis of inherited disease, 6th ed. {ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 547-562.
- Klebig, M.L., L.B. Russell, and E.M. Rinchik. 1992. Murine fu- marylacetoacetate hydrolase {Fahl gene is disrupted by a neonatally lethal albino deletion that defines the hepato- cyte-specific developmental regulation 1 {hsdr-1} locus. Proc. Natl. Acad. Sci. 89: 1363-1367.
- Leakey, J.E.A. 1983. Ontogenesis. In Biological basis of detox- ication led. J. Caldwell and W.B. lakoby), pp. 77-103. Aca- demic Press, New York.
- Loose, D.S., P.A. Shaw, K.S. Krauter, C. Robinson, S. Englard, R.W. Hanson, and S. Gluecksohn-Waelsch. 1986. Transreg- ulation of the phosphoenolpyruvate carboxykinase (GTP) gene, identified by deletions in chromosome 7 of the mouse. Proc. Natl. Acad. Sci. 83: 5184-5188.
- Miyai, K. 1979. Ultrastructural basis for toxic liver injury. In Toxic injury of the liver [ed. E. Farber and M.M. Fisherl, part A, pp. 59-130.
- Nitsch, D., M. Boshart, and G. Sch/itz. 1993. Activation of the tyrosine aminotransferase gene is dependent upon synergy between liver-specific and hormone-responsive elements. Proc. Natl. Acad. Sci. 90: 5479-5483.
- Petersen, D.D., F.J. Gonzalez, V. Rapic, C.A. Kozak, J.-Y. Lee, J.E. Jones, and D.W. Nebert. 1989. Marked increase in he- patic NAD{PIH:oxidoreductase gene transcription and mRNA levels correlated with a mouse chromosome 7 dele- tion. Proc. Natl. Acad. Sci. 86: 6699-6703.
- Rinchik, E.M. and L.B. Russell. 1990. Germ-line deletion mu- tations in the mouse: Tools for intensive functional and physical mapping of regions of the mammalian genome. In Genetic and physical mapping. Genome Analysis {ed. K.E. Davies and S.M. Tilghman), vol. I, pp. 121-158. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
- Ruiz-Bravo, N. and M.J. Ernest. 1982. Induction of tyrosine ami- notransferase mRNA by glucocorticoids and cAMP in fetal rat liver. Proc. Natl. Acad. Sci. 79: 365-368.
- Schmid, W., G. Miiller, G. Schfitz, and S. Gluecksohn-Waelsch. 1985. Deletions near the albino locus on chromosome 7 of the mouse affect the level of tyrosine aminotransferase mRNA. Proc. Natl. Acad. Sci. 82: 2866-2869.
- Shelly, L.L., K.-J. Lei, C.-J. Pan, S.F. Sakata, S. Ruppert, G. Schfitz, and J.Y. Chou. 1993. Isolation of the gene for murine glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1A. J. Biol. Chem. (in press).
- Talalay, P., M.J. De Long, and H.J. Prochaska. 1988. Identifica- tion of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. 85: 8261-8265.
- Zaret, K.S., P. Milos, M. Lia, D. Bali, and S. Gluecksohn- Waelsch. 1992. Selective loss of a DNase I hypersensitive site upstream of the tyrosine aminotransferase gene in mice homozygous for lethal albino deletions. Proc. Natl. Acad. Sci. 89: 6540-6544.
Cited by
Sorted by citations
Grompe, M., Lindstedt, S., Al-Dhalimy, M., Kennaway, N. G., Papaconstantinou, J., Torres-Ramos, C. A., Ou, C.-N., & Finegold, M. (1995) · Nature Genetics · doi:10.1038/ng0895-453 · Cited by 312 · see citing works
Aponte, J. L., Sega, G. A., Hauser, L. J., Dhar, M. S., Withrow, C. M., Carpenter, D. A., Rinchik, E. M., Culiat, C. T., & Johnson, D. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.641 · Cited by 68 · see citing works
- Authors
- Kelsey, G., Ruppert, S., Beermann, F., Grund, C., Tanguay, R. M., & Schutz, G.
- Affiliations
- German Cancer Research Center (DE)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1993-12-01
- Volume
- 7
- Issue
- 12a
- Pages
- 2285-2297
- ISSN
- 0890-9369 (ISSN-L)
- OpenAlex
- W1980430393
- Cited by
- 70
- References
- 4
- Citations by year
- 2023: 2 · 2021: 2 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 1
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Deutsche Forschungsgemeinschaft (SFB229)
- Medical Research Council Canada
- Medical Research Council
- Leibniz-Gemeinschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- tyrosinemia type I, fumarylacetoacetate hydrolase, transgenic complementation, tyrosine catabolism, animal models, liver disease
- MeSH terms
- Albinism, Animals, Disease Models, Animal, Homozygote, Humans, Hydrolases, Hypoglycemia, Liver, Liver Diseases, Mice, Transgenic, Phenotype, Tyrosine, Gene Expression, Gene Deletion, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review